LAMEA Contrast Injector Systems Market Analysis (2017-2023)

LAMEA Contrast Injector Systems Market Analysis (2017-2023)

  • January 2018 •
  • 93 pages •
  • Report ID: 5336614 •
  • Format: PDF
The LAMEA Contrast Injector Systems Market would witness market growth of 9.5% CAGR during the forecast period (2017 – 2023). Contrast injector systems are medical devices which use contrast media to improve the visibility of complex body structures, namely body fluids, tissues, arteries, and veins. The diagnostic process is conducted using various imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography.

Advanced healthcare spaces are swiftly adopting contrast injector techniques mainly because injector systems offer comprehensive imagery by way of computed tomography (CT), magnetic resonance imaging (MRI), angiography, and others. Technological innovations help with the development of inexpensive and entirely automated contrast injector approaches.

These kinds of automated contrast injectors support radiologist and other healthcare practitioners in reducing the odds of human error and making it possible for customized patient treatment. Nevertheless, the high-priced contrast injector systems combined with the hazards involved with contrast media impede the market expansion.

Based on product, the market report segments the market into Injector Systems, Consumables, and Accessories. Injector Systems further sub segmented into CT Injector Systems, MRI Injector Systems, and Angiography Injector Systems.

Consumables are further divided into Injector Head, Syringes, Tubing, and Other Consumables. The Application covered under the report includes Interventional Radiology, Interventional Cardiology, and Radiology. The end User covered under the report is Diagnostics Centers, Clinics & Others, and Hospitals .The report also covers geographical segmentation of Contrast Injector Systems market. The report also covers country wise segmentation of Contrast Injector Systems market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the LAMEA Contrast Injector Systems Market. Key companies profiled in the report include General Electric (GE), Medtron AG, VIVID Imaging, Nemoto Kyorindo Co., Ltd., Bayer AG, ulrich GmbH & Co. KG, Sino Medical-Device Technology Co., Ltd, Shenzhen Seacrown Electromechanical Co., Ltd, Bracco Imaging S.p.A, and Guerbet SA.